Since inception, we have served clients across the pharmaceutical, medical device, and diagnostics industries. We work with a range of management from business unit heads to CXOs of startups to major Fortune 100 companies. We have extensive experience in successfully realizing the clinical, financial, and regulatory objectives of our clients.
Our company is founded on three guiding principles:
What We Do
Business and Clinical Strategy
In a constantly evolving industry, our clients are faced with critical business and clinical choices on a regular basis. We enable them to make the right decisions by providing robust analytics and recommendations tailored to their individual needs. Our practical strategy solutions are based on a solid understanding of the issue(s), market dynamics, and other relevant factors to ensure complete client satisfaction.
Health Economics and Outcomes Research
In harmony with the evolving scope of health economics and outcomes research, our aim is to enable our clients to establish value that is relevant to stakeholders. We work closely with clients to create a suite of analytical models and other custom tools to accelerate value demonstration and decision making and support economic publications. Our solutions are specifically designed for each stakeholder, including payers, physicians, pharmacists, and hospital purchasers.
Medical and Technical Communications
In an increasingly informed digital world, we help our clients develop high impact communications targeted at corporate stakeholders, the scientific community, and even the general public. Our diverse portfolio, encompassing journal publications, conference posters, white papers, and other communications materials, ensures that even the most complex content is seamlessly delivered through a suitable medium to the intended audience.
We recognize that regulatory requirements and concerns are intricately woven into product development, launch, and life cycle planning. We provide regulatory insight, strategy, and writing support that complements our other core capabilities. We can support your strategy as you align the regulatory activities required to bring your product to market with your company’s core business objectives.
Our financial advisory team has a unique combination of technical and operational experience, so we can provide clients with in-depth knowledge on not only the financial challenges, but also the operational and regulatory challenges life science companies may face. With our unique structure, we can offer more flexibility around an engagement. Even if you are not in the proper place to execute a transaction, we can offer advice on how to best get there.
We are pleased to have served the needs of a wide range of life science organizations
What Our Clients Say
Rodgers, G. M., & Mahajerin, A. (2023). Antithrombin Therapy: Current
Antithrombin concentrates may benefit cardiopulmonary bypass patients with suspected heparin resistance: A retrospective analysis of real-world data
Bader, S. O., Marinaro, X. F., Stone, G., Lodaya, K.,
John W. Beard, Antra Sethi, Weiqi Jiao, Hayden W. Hyatt,
In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data
Izumi C, Matsuyama R, Yamabe K, Iwasaki K, Takeshima T,